JP2011530484A5 - - Google Patents

Download PDF

Info

Publication number
JP2011530484A5
JP2011530484A5 JP2011506509A JP2011506509A JP2011530484A5 JP 2011530484 A5 JP2011530484 A5 JP 2011530484A5 JP 2011506509 A JP2011506509 A JP 2011506509A JP 2011506509 A JP2011506509 A JP 2011506509A JP 2011530484 A5 JP2011530484 A5 JP 2011530484A5
Authority
JP
Japan
Prior art keywords
opc
antibody
markers
classified
progenitor cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011506509A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011530484A (ja
JP5794693B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2009/003195 external-priority patent/WO2010018652A1/en
Publication of JP2011530484A publication Critical patent/JP2011530484A/ja
Publication of JP2011530484A5 publication Critical patent/JP2011530484A5/ja
Application granted granted Critical
Publication of JP5794693B2 publication Critical patent/JP5794693B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011506509A 2008-08-13 2009-07-08 神経分化促進剤 Expired - Fee Related JP5794693B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8852108P 2008-08-13 2008-08-13
US61/088,521 2008-08-13
PCT/JP2009/003195 WO2010018652A1 (en) 2008-08-13 2009-07-08 Agent for promoting neuronal differentiation and method therefor

Publications (3)

Publication Number Publication Date
JP2011530484A JP2011530484A (ja) 2011-12-22
JP2011530484A5 true JP2011530484A5 (enExample) 2012-08-23
JP5794693B2 JP5794693B2 (ja) 2015-10-14

Family

ID=41668806

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011506509A Expired - Fee Related JP5794693B2 (ja) 2008-08-13 2009-07-08 神経分化促進剤

Country Status (6)

Country Link
US (1) US20110183912A1 (enExample)
EP (1) EP2326333B1 (enExample)
JP (1) JP5794693B2 (enExample)
AU (1) AU2009280769B2 (enExample)
CA (1) CA2733775A1 (enExample)
WO (1) WO2010018652A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012112737A2 (en) * 2011-02-16 2012-08-23 The Regents Of The University Of California Alzheimer's disease cellular model for diagnostic and therapeutic development
WO2013162027A1 (ja) * 2012-04-27 2013-10-31 学校法人 慶應義塾 神経分化促進剤
US11332719B2 (en) * 2013-03-15 2022-05-17 The Broad Institute, Inc. Recombinant virus and preparations thereof
WO2019222134A1 (en) * 2018-05-14 2019-11-21 Baylor College Of Medicine Coup-tfii receptor inhibitors and methods using same
WO2023201361A1 (en) 2022-04-15 2023-10-19 Aspen Neuroscience, Inc. Methods of classifying the differentiation state of cells and related compositions of differentiated cells
CN116162657A (zh) * 2022-11-21 2023-05-26 中国人民解放军军事科学院军事医学研究院 一种促进神经干细胞增殖和向神经元分化的方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8760298A (en) * 1997-08-01 1999-02-22 Baylor College Of Medicine Coup-tfi directed therapies in the treatment of disease
US6395546B1 (en) * 2000-02-01 2002-05-28 Neurogeneration, Inc. Generation of dopaminergic neurons from human nervous system stem cells
JP3660601B2 (ja) 2001-03-30 2005-06-15 独立行政法人科学技術振興機構 胚性幹細胞からの神経幹細胞、運動ニューロン及びgaba作動性ニューロンの製造法
WO2003046141A2 (en) * 2001-11-26 2003-06-05 Advanced Cell Technology, Inc. Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
WO2005017112A2 (en) * 2003-08-05 2005-02-24 Immusol Incorporated Methods of inhibiting cancer growth by binding to nuclear receptors
US20070184459A1 (en) * 2006-02-03 2007-08-09 Immusol Incorporated Methods of inhibiting cancer growth by binding to nuclear receptors

Similar Documents

Publication Publication Date Title
JP2012512958A5 (enExample)
JP2011506530A5 (enExample)
JP2011526312A5 (enExample)
JP2011530484A5 (enExample)
JP2012098988A5 (enExample)
JP2012531154A5 (enExample)
JP2012508366A5 (enExample)
MX345044B (es) Métodos para el diagnóstico de trastornos oncológicos usando cambiadores epimetabólicos, moléculas intracelulares multidimensionales o influenciadores ambientales.
JP2010538767A5 (enExample)
EP2424975A4 (en) Organisms for the production of 1,3-butanediol
EP1976046A4 (en) FUEL CELL SEPARATOR, PROCESS FOR PRODUCTION THEREOF, AND FUEL CELL COMPRISING SAID SEPARATOR
JP2010521616A5 (enExample)
ATE541909T1 (de) Klebstoff
JP2012502876A5 (enExample)
JP2011004745A5 (enExample)
JP2014519854A5 (enExample)
JP2013500200A5 (enExample)
WO2011160827A3 (en) Novel jnk inhibitor molecules
JP2010505386A5 (enExample)
BR112013011417A2 (pt) microrganismos para a produção de 1,3-propanodiol usando alta concentração de glicerina
JP2008278122A5 (enExample)
JP2013531183A5 (enExample)
JP2011063849A5 (enExample)
JP2010285408A5 (enExample)
JP2007530049A5 (enExample)